1. Home
  2. XLO

as 05-08-2025 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

Founded: 2016 Country:
United States
United States
Employees: N/A City: WALTHAM
Market Cap: 42.2M IPO Year: 2021
Target Price: $4.00 AVG Volume (30 days): 184.0K
Analyst Decision: Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.83 EPS Growth: N/A
52 Week Low/High: $0.62 - $1.70 Next Earning Date: 05-08-2025
Revenue: $9,274,000 Revenue Growth: N/A
Revenue Growth (this year): 668.96% Revenue Growth (next year): 14.49%

XLO Daily Stock ML Predictions

Share on Social Networks: